Last update Oct. 9, 2016
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
μεπυραμίνη is Mepyramine in Greek.Is written in other languages:
μεπυραμίνη is also known as
μεπυραμίνη belongs to these groups or families:
Main tradenames from several countries containing μεπυραμίνη in its composition:
|Tmax||2 - 4||hours|
|T½||3 - 3.5||hours|
Write us at email@example.com
e-lactancia is a resource recommended by Asociación Pro Lactancia Materna (APROLAM) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
First generation antihistamine with sedative and important antimuscarinic effects. Such remarkable anticholinergic effect may inhibit lactation.
At latest update no published data on excretion into breast milk were found.
Drug with poor scientific support which is marketed in very few countries.
Marketed as part of in many “at the counter” compounds in association poliasociación with expectorants, bronchodilators, antitussives, etc. Avoid the use of drug associations mostly while breastfeeding.
Although occasional and moderate use during lactation would probably not pose a serious risk, a safer alternative should be preferred until more data on this drug related to breastfeeding is available.
Topically used on the skin, it would not represent a risk during breastfeeding. Avoid applying it on the breast.
Assess the child for drowsiness and inappropriate infant feeding.
It is not recommended bed-sharing with your baby if you are on this medication.